Obviously, compound 20a significantly inhibited IDO1 activity in tumor tissues and reduced Kyn level in plasma with IDO1 inhibitory IC50 value of 0.13 μM and antiproliferative EC50 (half maximal effect concentration) value of 0.27 μM aganist HeLa cells. The gene discussed is IDO1; the disease is neoplasm.